| Preparation of hybrid alginate-chitosan aerogel as potential carriers for pulmonary drug delivery M Alnaief, RM Obaidat, MM Alsmadi Polymers 12 (10), 2223, 2020 | 45 | 2020 |
| Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment MM Alsmadi, RM Obaidat, M Alnaief, BA Albiss, N Hailat AAPS PharmSciTech 21, 1-12, 2020 | 44 | 2020 |
| Enhancement of the dissolution and bioavailability from freeze-dried powder of a hypocholesterolemic drug in the presence of Soluplus M Khanfar, B Al-Taani, M Alsmadi, A Zayed Powder Technology 329, 25-32, 2018 | 19 | 2018 |
| Pharmacy education in Jordan: updates Q Alefan, MM Alsmadi International Journal of Pharmacy Practice 25 (6), 418-420, 2017 | 18 | 2017 |
| The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney … MM Alsmadi, MQ Alfarah, J Albderat, G Alsalaita, R AlMardini, S Hamadi, ... Biopharmaceutics & Drug Disposition 40 (9), 325-340, 2019 | 16 | 2019 |
| Optimization of drugs pharmacotherapy during pregnancy using physiologically based pharmacokinetic models-an update MM Alsmadi, N Idkaidek Current Drug Metabolism 19 (12), 972-978, 2018 | 16 | 2018 |
| Physiologically‐based pharmacokinetic model for alectinib, ruxolitinib, and panobinostat in the presence of cancer, renal impairment, and hepatic impairment MM Alsmadi, NM AL‐Daoud, MM Jaradat, SB Alzughoul, AD Abu Kwiak, ... Biopharmaceutics & drug disposition 42 (6), 263-284, 2021 | 15 | 2021 |
| Sublingual spray drug delivery of ketorolac-loaded chitosan nanoparticles S Baltzley, AA Malkawi, M Alsmadi, AM Al-Ghananeem Drug Development and Industrial Pharmacy 44 (9), 1467-1472, 2018 | 14 | 2018 |
| The development of a PBPK model for atomoxetine using levels in plasma, saliva and brain extracellular fluid in patients with normal and deteriorated kidney function MM Alsmadi, LN Al Eitan, NM Idkaidek, KH Alzoubi CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 10 | 2022 |
| Development and evaluation of cocoa butter taste masked ibuprofen using supercritical carbon dioxide R Obaidat, H Aleih, H Mashaqbeh, B Altaani, MM Alsmadi, M Alnaief AAPS PharmSciTech 22, 1-13, 2021 | 10 | 2021 |
| Saliva versus plasma therapeutic drug monitoring of gentamicin in Jordanian preterm infants. Development of a physiologically-based pharmacokinetic (PBPK) model and validation … N Idkaidek, S Hamadi, R Bani-Domi, I Al-Adham, M Alsmadi, F Awaysheh, ... Drug Research 70 (10), 455-462, 2020 | 10 | 2020 |
| The analysis of pethidine pharmacokinetics in newborn saliva, plasma, and brain extracellular fluid after prenatal intrauterine exposure from pregnant mothers receiving … MM Alsmadi, N Idkaidek European Journal of Drug Metabolism and Pharmacokinetics 48 (3), 281-300, 2023 | 7 | 2023 |
| Delivery of peptidic gonadotropin releasing hormone antagonists RY AlSheyyab, BM Al-Taani, RM Obeidat, MM Alsmadi, RK Masaedeh, ... Current Drug Delivery 15 (5), 602-609, 2018 | 5 | 2018 |
| The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic … MM Alsmadi Drug Metabolism and Personalized Therapy 38 (1), 87-105, 2023 | 4 | 2023 |
| Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by … M Motasem Alsmadi, NM AL-Daoud, RM Obaidat, NA Abu-Farsakh AAPS PharmSciTech 23, 2022 | 4 | 2022 |
| Technical insight into biodegradable polymers used in implants R Masadeh, R Obaidat, M Alsmadi, B Altaani, M Khanfar, R Alshyab, ... Jordan Journal of Pharmaceutical Sciences 11 (3), 2018 | 4 | 2018 |
| Evaluating the pharmacokinetics of fentanyl in the brain extracellular fluid, saliva, urine, and plasma of newborns from transplacental exposure from parturient mothers dosed … MM Alsmadi European Journal of Drug Metabolism and Pharmacokinetics 48 (5), 567-586, 2023 | 3 | 2023 |
| Insights into the mapping of green synthesis conditions for ZnO nanoparticles and their toxicokinetics MM Alsmadi, NK Al-Nemrawi, R Obaidat, AE Abu Alkahsi, KM Korshed, ... Nanomedicine 17 (18), 1281-1303, 2022 | 2 | 2022 |
| Physiologically based pharmacokinetic (PBPK) model of Ivermectin (IVM) MM Alsmadi Ph. D. Thesis, 2014 | 2 | 2014 |
| Salivary therapeutic monitoring of methadone toxicity in neonates after transplacental transfer from parturient mothers treated with oral methadone guided by PBPK modeling MA Mo'tasem Computational Toxicology 29, 100296, 2024 | 1 | 2024 |
